Brief: Australian Clinical Labs Ltd Says Update On Offer For Healius
14/09/2023 02:33
Sept 14 (Reuters) - Australian Clinical Labs Ltd
ACL.AX :
* UPDATE ON OFFER FOR HEALIUS AND POSTPONEMENT OF EGM,HLS
* ACL CONTINUES TO BELIEVE THAT PROPOSED MERGER IS MOST
VALUE
ACCRETIVE OPTION FOR HEALIUS AND ACL SHAREHOLDERS
Source text for Eikon: ID:nASX17NnG9
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028